This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Ceccarelli, P. Articles by Melendez, L. Search for Related Content PubMed PubMed Citation Articles by Ceccarelli, P. Articles by Melendez, L.

---

GENERAL ARTICLES

Inhaled Nitric Oxide Delivery by Anesthesia Machines

Department of Anesthesia and Critical Care and the Respiratory Care Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Address correspondence to Luca M. Bigatello, MD, Department of Anesthesia and Critical Care, Clinics 3, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. Address e-mail to lbigatello{at}partners.org

Inhaled nitric oxide (NO) is a selective pulmonary vasodilator used to treat intraoperative pulmonary hypertension and hypoxemia. In contrast to NO delivered by critical care ventilators, NO delivered by anesthesia machines can be complicated by rebreathing. We evaluated two methods of administering NO intraoperatively: via the nitrous oxide (N₂O) flowmeter and via the INOvent (Datex-Ohmeda, Madison, WI). We hypothesized that both systems would deliver NO accurately when the fresh gas flow (FGF) rate was higher than the minute ventilation (E). Each system was set to deliver NO to a lung model. Rebreathing of NO was obtained by decreasing FGF and by simulating partial NO uptake by the lung. At FGF E (6 L/min), both systems delivered an inspired NO concentration ([NO]) within approximately 10% of the [NO] set. At FGF < E and complete NO uptake, the N₂O flowmeter delivered a lower [NO] (70 and 40% of the [NO] set at 4 and 2 L/min, respectively) and the INOvent delivered a higher [NO] (10 and 23% higher than the [NO] set at 4 and 2 L/min, respectively). Decreasing the NO uptake increased the inspired [NO] similarly with both systems. At 4 L/min FGF, [NO] increased by 10%–20% with 60% uptake and by 18%–23% with 30% uptake. At 2 L/min, [NO] increased by 30%–33% with 60% uptake and by 60%–69% with 30% uptake. We conclude that intraoperative NO inhalation is accurate when administered either by the N₂O flowmeter of an anesthesia machine or by the INOvent when FGF E.

Implications: Inhaled nitric oxide (NO) is a selective pulmonary vasodilator. In a lung model, we demonstrated that NO can be delivered accurately by a N₂O flowmeter or by a commercial device. We provide guidelines for intraoperative NO delivery.

This article has been cited by other articles:

				D. E. Supkis Jr, L. Bigatello, W. Hurford, and D. Hess Nitric Oxide Delivery System Response Anesth. Analg., October 1, 2000; 91(4): 1041 - 1042. [Full Text] [PDF]